权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

EXCIPLEX PHOTOREACTIVITY IN PHOTOTOXIC COMPOUNDS

光毒性化合物中的 EXCIPLEX 光反应性

基本信息

批准号：
3156898
负责人：
GARY A EPLING
金额：
$ 7.46万
依托单位：
UNIVERSITY OF CONNECTICUT STORRS
依托单位国家：
美国
项目类别：
财政年份：
1984
资助国家：
美国
起止时间：
1984-12-01 至 1988-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/3156898
关键词：
DNA antihistamines antimalarial agents cell membrane cytotoxicity drug adverse effect edema erythema light adverse effect neuropharmacologic agent nonvisual photosensitivity phenothiazines photochemistry photostimulus quinine sedative /hypnotic sunburn

项目摘要

Ingestion of many synthetic drugs (as well as many naturally-occurring compounds) produces 'phototoxicity" in humans and animals, so that subsequent exposure to light causes skin or vision damage. Examples of pharmacologically active compounds which have been observed to cause severe or frequent phototoxic reactions in humans are phenothiazines (which are antihistamines, sedatives, or antipsychotic drugs), quinolinemethanol antimalarial compounds (which are quinine analogs), and the benzo-cycloheptadiene antidepressant compounds. To synthetically modify these drugs to avoid this side effect is a difficult challenge because of great uncertainty about the molecular and mechanistic cause of this undesired photobiological activity of these compounds. We propose to clarify the chemical mechanisms which cause phototoxicity in these compounds (which are representative of other phototoxic drugs which may react by similar mechanisms). For our study we will focus on in vitro studies which use micelles as models for the actual microenvironment of the drugs in vivo. The in vivo environment will be carefully modeled by sequestering within a micelle both the phototoxic drug and reactive substrates which would closely parallel the reactive functionalities present in proteins, DNA, or a cell membrane. Thus, a chemical reaction occurring in our micelle models should parallel that which occur with a phototoxic drug that is protein-bound, intercalated with DNA, or buried within a cell membrane. The range of clinical manifestations of photochemical reactivity of phototoxic compounds is great, including not only skin reactions of erythema and edema which parallel an exaggerated sunburn response, but also photocarcinogenesis and photomutagenesis (reflecting DNA damage), photoallergy (reflecting protein damage), and cytotoxic reactions which seem to involve membrane destruction. Our study will focus on attempting to recognize common features among compounds that are phototoxic, focusing on the likely involvement of excited states which are charge transfer or exciplex in nature. It is felt that such species are particularly likely to undergo undesired photoreactivity in the presence of biopolymers.

摄入许多合成药物（以及许多天然存在的药物）化合物）对人类和动物产生“光毒性”，因此随后暴露在光线下会导致皮肤或视力受损。的例子已观察到可引起严重后果的药理活性化合物或在人类中频繁发生光毒性反应的是吩噻嗪类药物（它们是抗组胺药、镇静剂或抗精神病药）、喹啉甲醇抗疟化合物（奎宁类似物），以及苯并环庚二烯抗抑郁化合物。综合修改使用这些药物来避免这种副作用是一项艰巨的挑战，因为其分子和机制原因存在很大的不确定性这些化合物的不期望的光生物活性。我们建议阐明引起光毒性的化学机制化合物（代表其他光毒性药物，可能通过类似的机制做出反应）。对于我们的研究，我们将重点关注使用胶束作为药物体内实际微环境的模型。体内环境将通过在胶束内隔离来仔细建模光毒性药物和反应底物将密切平行蛋白质、DNA 或细胞膜中存在的反应功能。因此，我们的胶束模型中发生的化学反应应该平行进行与蛋白质结合、嵌入的光毒性药物发生的情况与 DNA 一起，或埋在细胞膜内。光化学反应性的临床表现范围光毒性化合物很大，不仅包括皮肤反应红斑和水肿与夸张的晒伤反应相似，但也光致癌和光致突变（反映 DNA 损伤），光过敏（反映蛋白质损伤）和细胞毒性反应似乎涉及膜破坏。我们的研究将集中于尝试识别光毒性化合物的共同特征，聚焦关于电荷转移或激发态的可能参与自然界中的激基复合物。人们认为此类物种特别有可能在生物聚合物存在的情况下发生不需要的光反应性。